Skip to main content
main-content

13-12-2019 | Breast cancer | Video

SABCS 2019 | Menopausal hormone therapy and breast cancer risk

Rowan Chlebowski outlines the findings from the Women's Health Initiative trials investigating the effect of oestrogen, either alone or with progestin, on breast cancer risk, and puts them in context of recent opposing data (4:10).

Funding for independent interviews at SABCS 2019 was provided by F. Hoffmann-La Roche Ltd, Basel, Switzerland.